We are live on ! Find out more
CIBC Asset Management

CIBC Asset Management Portfolio holdings

AUM $45.6B
1-Year Est. Return 44.74%
This Fund
S&P 500
This Quarter Est. Return
+5.4%
1 Year Est. Return
+44.74%
3 Year Est. Return
+112.06%
5 Year Est. Return
+130.24%
10 Year Est. Return
+357.85%
AUM
$26.1B
AUM Growth
+$862M
Cap. Flow
-$231M
Cap. Flow %
-0.89%
Top 10 Hldgs %
30.17%
Holding
1,124
New
59
Increased
231
Reduced
607
Closed
25

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$52.4M
2
TRI icon
Thomson Reuters
TRI
+$46.6M
3
CP icon
Canadian Pacific Kansas City
CP
+$43.5M
4
TD icon
Toronto Dominion Bank
TD
+$42.6M
5
FTS icon
Fortis
FTS
+$33.9M

Top Sells

Rank Stock Value
1
BKLN icon
Invesco Senior Loan ETF
BKLN
+$90.8M
2
BN icon
Brookfield
BN
+$65.9M
3
ACN icon
Accenture
ACN
+$57.6M
4
MFC icon
Manulife Financial
MFC
+$52.4M
5
TU icon
Telus
TU
+$40.9M

Sector Composition

Rank Sector Weight
1 Financials 23.98%
2 Technology 13.84%
3 Energy 11.67%
4 Industrials 10.1%
5 Miscellaneous 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIM
1051
Chimera Investment
CIM
$964M
$69K ﹤0.01%
3,987
SLDB icon
1052
Solid Biosciences
SLDB
$1.09B
$63.3K ﹤0.01%
12,083
SFT
1053
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$62.9K ﹤0.01%
28,995
AMC icon
1054
AMC Entertainment Holdings
AMC
$2.41B
$62.4K ﹤0.01%
1,418
CYH icon
1055
Community Health Systems
CYH
$413M
$62.3K ﹤0.01%
14,164
PBI icon
1056
Pitney Bowes
PBI
$2.37B
$60.6K ﹤0.01%
17,110
HPP
1057
Hudson Pacific Properties
HPP
$736M
$59.5K ﹤0.01%
2,013
BIOR
1058
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$58.2K ﹤0.01%
1,511
MQ icon
1059
Marqeta
MQ
$1.69B
$57.6K ﹤0.01%
2,959
MVLA
1060
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$56.7K ﹤0.01%
26,616
VANI icon
1061
Vivani Medical
VANI
$126M
$56.4K ﹤0.01%
46,591
OPEN icon
1062
Opendoor
OPEN
$3.28B
$54.1K ﹤0.01%
13,909
THRD
1063
DELISTED
Third Harmonic Bio
THRD
$50.9K ﹤0.01%
10,573
EMBK
1064
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$48.9K ﹤0.01%
17,092
FAZE
1065
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$48.7K ﹤0.01%
98,744
NN icon
1066
NextNav
NN
$2.65B
$48.5K ﹤0.01%
16,512
SYRS
1067
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$48.5K ﹤0.01%
15,398
BGXX
1068
DELISTED
Bright Green Corporation Common Stock
BGXX
$48.2K ﹤0.01%
47,699
DNA icon
1069
Ginkgo Bioworks
DNA
$489M
$46.7K ﹤0.01%
628
BGC icon
1070
BGC Group
BGC
$5.75B
$44.7K ﹤0.01%
10,090
PET
1071
DELISTED
Wag!
PET
$44.1K ﹤0.01%
20,989
COSM icon
1072
Cosmos Holdings
COSM
$21.8M
$42.5K ﹤0.01%
14,226
DC icon
1073
Dakota Gold
DC
$837M
$40.1K ﹤0.01%
13,739
AKLI
1074
DELISTED
Akili Inc
AKLI
$38.6K ﹤0.01%
34,807
GERN icon
1075
Geron
GERN
$983M
$37.3K ﹤0.01%
11,633

Similar funds

CIBC Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, CIBC Asset Management held 1,124 positions worth $26.1B, up 3.4% from $25.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

CIBC Asset Management's Q2 2023 filing shows 59 new, 231 increased, 607 reduced and 25 closed positions. Its largest new stake was ATS Corp: 398,332 shares worth $18.3M. The largest sale was Invesco Senior Loan ETF, an estimated $90.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Energy.

  • CIBC Asset Management's largest Q2 2023 buy was ATS Corp: 398,332 shares worth $18.3M.
  • CIBC Asset Management added most to Nutrien in Q2 2023, an estimated $52.4M increase.
  • CIBC Asset Management's biggest Q2 2023 reduction was Invesco Senior Loan ETF, cutting an estimated $90.8M.
  • CIBC Asset Management fully exited State Street SPDR S&P Bank ETF in Q2 2023, selling an estimated $29.3M.
  • CIBC Asset Management's ten largest holdings make up 30% of its $26.1B portfolio in Q2 2023.
  • CIBC Asset Management opened 59 new positions and closed 25 in Q2 2023.
  • CIBC Asset Management's portfolio value rose 3.4% quarter-over-quarter to $26.1B.

Based on CIBC Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.